BDBM85517 CAS_171436-38-7::SL-NH2::SLIGRL-NH2
SMILES: [#6]-[#6]-[#6@H](-[#6])-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-[#8])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](-[#7])=O
InChI Key: InChIKey=SGPMJRPYYIJZPC-JYAZKYGWSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F2RL1 (RAT) | BDBM85517 (CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | PubMed | 260 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Calgary Curated by PDSP Ki Database | J Pharmacol Exp Ther 290: 753-60 (1999) BindingDB Entry DOI: 10.7270/Q2N878BQ | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM85517 (CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a |
The University of Queensland Curated by ChEMBL | Assay Description Agonist activity at PAR2 (unknown origin) by cell-based assay | J Med Chem 56: 7477-97 (2013) Article DOI: 10.1021/jm400638v BindingDB Entry DOI: 10.7270/Q2NC62MG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM85517 (CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
ACADIA Pharmaceuticals AB Curated by ChEMBL | Assay Description Agonist activity at human PAR2 expressed in HEK293T cells assessed as effect on intracellular calcium mobilization by R-SAT assay | J Med Chem 51: 5490-3 (2008) Article DOI: 10.1021/jm800754r BindingDB Entry DOI: 10.7270/Q290251P | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM85517 (CAS_171436-38-7 | SL-NH2 | SLIGRL-NH2) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 4.20E+3 | n/a | n/a | n/a | n/a |
The University of Queensland Curated by ChEMBL | Assay Description Agonist activity at PAR2 in human HT-29 cells assessed as increase in intracellular calcium release | J Med Chem 56: 7477-97 (2013) Article DOI: 10.1021/jm400638v BindingDB Entry DOI: 10.7270/Q2NC62MG | |||||||||||
More data for this Ligand-Target Pair |